Analytical Data
-
Gene name
RB1CC1
- Application
-
Alternative Names
FAK family kinase-interacting protein of 200 kDa (FIP200) (KIAA0203) (RBICC)
-
Species
Human
-
Source
E. coli
-
Tag
N- His & C- Myc
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8TDY2
-
Expression Region
1241-1594aa
-
Molecular Weight
47.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
RB1CC1, also known as FAM117B, is a protein associated with various cellular functions, including cell cycle regulation, apoptosis, and metabolism. It plays a distinctive role in mediating cell proliferation and survival, linking the retinoblastoma (RB) tumor suppressor pathway with core cellular processes. The gene encoding RB1CC1 is often studied in the context of cancer biology, as aberrations in its expression and function can contribute to tumorigenesis. Researchers have discovered that RB1CC1 may influence the stability of other proteins, thereby impacting cellular signaling pathways that govern growth and differentiation. Investigating the recombinant form of RB1CC1 allows scientists to delve deeper into its structural properties and functional mechanisms. This understanding is crucial for developing therapeutic strategies aimed at manipulating these pathways in cancer treatment and understanding its role in other diseases. Furthermore, the production of RB1CC1 as a recombinant protein opens avenues for high-throughput screening and interaction studies, propelling research forward in both basic biology and clinical applications. Consequently, the exploration of RB1CC1 provides valuable insights not only into cancer biology but also in potential therapeutic interventions.
